Immutep announces poster presentation for the TACTI-004 Phase III trial
PremiumThe FlyImmutep announces poster presentation for the TACTI-004 Phase III trial
17d ago
Immutep to Present Pivotal Lung Cancer Trial at ELCC 2025
Premium
Company Announcements
Immutep to Present Pivotal Lung Cancer Trial at ELCC 2025
17d ago
Immutep Ltd Reports Increased Income Amid Rising R&D Costs
Premium
Company Announcements
Immutep Ltd Reports Increased Income Amid Rising R&D Costs
1M ago
Immutep reports Q2 cash receipts from customers A$8,000
PremiumThe FlyImmutep reports Q2 cash receipts from customers A$8,000
2M ago
Immutep announces patient enrollment completed for EFTISARC-NEO Phase II trial
Premium
The Fly
Immutep announces patient enrollment completed for EFTISARC-NEO Phase II trial
2M ago
Immutep Completes Patient Enrolment for Key Phase II Cancer Trial
Premium
Company Announcements
Immutep Completes Patient Enrolment for Key Phase II Cancer Trial
2M ago
Immutep Reveals Promising Data for IMP761 Trial
PremiumCompany AnnouncementsImmutep Reveals Promising Data for IMP761 Trial
4M ago
Immutep, Monash University announce publication on human LAG-3
Premium
The Fly
Immutep, Monash University announce publication on human LAG-3
4M ago
Immutep Ltd Reveals Key LAG-3 Binding Discovery
Premium
Company Announcements
Immutep Ltd Reveals Key LAG-3 Binding Discovery
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100